DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Chronic Obstructive Pulmonary Disease Market Analysis 2016 - Forecast to 2022" report to their offering.
This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.
This report analyzes the global markets for "Chronic Obstructive Pulmonary Disease". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America).
Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments.
- Boehringer Ingelheim
- Rottapharm | Madaus
Key Topics Covered:
2 Executive Summary
3 Market Analysis
4 Porters Five Force Analysis
5 Chronic Obstructive Pulmonary Disease Market by Product
6 Geographical Segmentation
7 Vendor Landscaping
8 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/gs8f6l/global_chronic